Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Loratadine fumarate vs desloratadine for allergic rhinitis
CTR20140246Phase 2Completed
- Sponsor
- Nanjing Huawei Pharmaceutical Technology Development
- Start
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of rupatadine in allergic rhinitis (AR), seasonal allergic rhinitis (SAR), perennial rhinitis, sponsored by Nanjing Huawei Pharmaceutical Technology Development. Started Jul 2014; status: completed.
02
Drugs
rupatadine
03
Conditions
allergic rhinitis (AR)seasonal allergic rhinitis (SAR)perennial rhinitis
Beyond the preview
Go deeper on CTR20140246.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140246.